Found 380 matching trials
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients PHASE1 Considerable progress in the treatment of metastatic melanoma has been made...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine PHASE1 In December 2019, viral pneumonia caused by a novel beta-coronavirus (Covid...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer PHASE1 This is a single-arm, multicenter, phase II study designed to evaluate the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Cellular Immunotherapy Study for Brain Cancer PHASE1 The purpose of this research study to determine if treating recurrent malig...
Show More Location
University of California, Los Angeles
Learn More & Join Trial
GKL-006Allo Injection in Patients With Advanced Solid Tumors PHASE1 This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia PHASE1 This phase I trial studies the side effects and best dose of ipilimumab and...
Show More Learn More & Join Trial
Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE2 This randomized phase II trial studies how well nivolumab works with or wit...
Show More Location
Sutter Auburn Faith Hospital
Learn More & Join Trial
Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02) PHASE1 Substudy 02B is part of a larger research study where researchers are looki...
Show More Location
The Angeles Clinic and Research Institute ( Site 2009)
Learn More & Join Trial
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery PHASE2 This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Show More Location
Loyola University Medical Center
Learn More & Join Trial
Resection+Highly Purified CTL Versus Resection Alone for HCC PHASE3 There is little evidence showed that adjuvant therapy had been shown to ext...
Show More Location
Multiple Locations
Learn More & Join Trial